Exendin-4, a glucagon-like peptide-1 receptor agonist, attenuates neointimal hyperplasia after vascular injury.
about
Anti-atherogenic and anti-inflammatory properties of glucagon-like peptide-1, glucose-dependent insulinotropic polypepide, and dipeptidyl peptidase-4 inhibitors in experimental animalsEffects of glucagon-like peptide-1 receptor agonists on non-alcoholic fatty liver disease and inflammationLiraglutide attenuates high glucose-induced abnormal cell migration, proliferation, and apoptosis of vascular smooth muscle cells by activating the GLP-1 receptor, and inhibiting ERK1/2 and PI3K/Akt signaling pathways.Exendin-4 Prevents Vascular Smooth Muscle Cell Proliferation and Migration by Angiotensin II via the Inhibition of ERK1/2 and JNK Signaling Pathways.Metabolic Syndrome Abolishes Glucagon-Like Peptide 1 Receptor Agonist Stimulation of SERCA in Coronary Smooth MuscleThe GLP-1 receptor agonists exendin-4 and liraglutide alleviate oxidative stress and cognitive and micturition deficits induced by middle cerebral artery occlusion in diabetic mice.Glucagon-like peptide-1 secretory function as an independent determinant of blood pressure: analysis in the Tanno-Sobetsu study.PSCs and GLP-1R: occurrence in normal pancreas, acute/chronic pancreatitis and effect of their activation by a GLP-1R agonist.Cardiovascular Benefits of Native GLP-1 and its Metabolites: An Indicator for GLP-1-Therapy Strategies.Vascular Smooth Muscle as a Target for Novel Therapeutics.Attenuation of carotid neointimal formation after direct delivery of a recombinant adenovirus expressing glucagon-like peptide-1 in diabetic rats.The role of endothelial nitric oxide in the anti-restenotic effects of liraglutide in a mouse model of restenosis.Exenatide Inhibits the KCa3.1 Channels of Aortic Vascular Smooth Muscle in Diabetic Rats.Exendin-4 alleviates angiotensin II-induced senescence in vascular smooth muscle cells by inhibiting Rac1 activation via a cAMP/PKA-dependent pathway.Combining Pathway Identification and Breast Cancer Survival Prediction via Screening-Network Methods.
P2860
Q26749176-D245F11F-A99F-4425-914A-DCC6B9DA0A8AQ34405101-278A5193-3D27-45C8-AB4B-812C69CA1076Q35082511-83F4D397-FABE-4DA4-9D2C-0A34E56099AAQ35778740-FC0F25BF-8BA1-4A1B-A536-36A58BB7887CQ35973848-58B2896F-7DAC-437D-A510-65E824275F65Q36051056-6FA4021D-48B8-4033-B67F-3D3B9BD796F2Q36976775-FE684EA1-302C-4029-94E6-2FFA99537B15Q37428774-6A4E7F02-09DE-4C4C-9C43-39E16FFEAD8CQ37611715-16D67BC7-64A5-45FC-85A2-87535550DDE0Q38567506-A87B3DAA-943A-444E-8B0F-A5C04BD2C919Q42032473-59970245-1398-4534-ABC3-8C764E86924DQ42284707-D91FCC57-86BE-40CB-BEE8-69368EDA5B3CQ47096372-80AF472E-FE89-4249-84C9-D7A123D58F82Q54316655-7D7782F4-F4A9-4A3F-A369-14D2EDF1B645Q55369745-C053D49D-F4FC-446D-AAD1-4A2EFF053851
P2860
Exendin-4, a glucagon-like peptide-1 receptor agonist, attenuates neointimal hyperplasia after vascular injury.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Exendin-4, a glucagon-like pep ...... rplasia after vascular injury.
@en
Exendin-4, a glucagon-like pep ...... rplasia after vascular injury.
@nl
type
label
Exendin-4, a glucagon-like pep ...... rplasia after vascular injury.
@en
Exendin-4, a glucagon-like pep ...... rplasia after vascular injury.
@nl
prefLabel
Exendin-4, a glucagon-like pep ...... rplasia after vascular injury.
@en
Exendin-4, a glucagon-like pep ...... rplasia after vascular injury.
@nl
P2093
P1476
Exendin-4, a glucagon-like pep ...... rplasia after vascular injury.
@en
P2093
Chika Nishio
Daiju Fukuda
Etsuko Uematsu
Hiroshi Sakaue
Hirotsugu Kurobe
Kimie Tanaka
Masataka Sata
Nagakatsu Harada
Sachiko Nishimoto
Takeshi Soeki
P304
P356
10.1016/J.EJPHAR.2012.11.057
P407
P577
2012-12-07T00:00:00Z